What is Kazia Therapeutics Ltd ADR (KZIA) stock price today?

Kazia Therapeutics Ltd ADR (KZIA) currently trades at $13.64 per share. The stock has a market capitalization of $135.07M and a P/E ratio of —x.

Is KZIA stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Kazia Therapeutics Ltd ADR has a Smart Value Score of 36/100 (Grade D), resulting in a "Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is Kazia Therapeutics Ltd ADR's revenue and earnings?

Kazia Therapeutics Ltd ADR has trailing twelve-month (TTM) revenue of $1.90M with profit margins of 0.00%. Earnings per share (EPS) is $-7.61.

KZIA

Kazia Therapeutics Ltd ADR

NASDAQ: KZIA · HEALTHCARE · BIOTECHNOLOGY

$13.64

+9.82% today

Updated 2026-04-30

Market cap

$135.07M

P/E ratio

—

P/S ratio

71.14x

EPS (TTM)

$-7.61

Dividend yield

—

52W range

$3 – $17

Volume

0.2M

Market cap

$135.07M

P/E ratio

—

P/S ratio

71.14x

EPS (TTM)

$-7.61

Dividend yield

—

52W range

$3 – $17

Volume

0.2M

WallStSmart proprietary scores

out of 100

Grade: D

Sell

Investment rating

8.0

Growth

5.0

Quality

C+

2.5

Profitability

5.3

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →202 stocks currently score above 75

Price targets

Analyst target

$21.26

+55.87%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

1 Strong Buy1 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Revenue growth 312.40% QoQ

Risks

- Thin margins at 0.00%

- Negative free cash flow $-9.07M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$10000.00	$555.00	$2.31M	$42000.00	$1.90M
Net income	$-25.01M	$-20.47M	$-26.78M	$-20.70M	$-12.32M
EPS	—	—	—	—	$-7.61
Free cash flow	$-22.76M	$-15.16M	$-9.58M	$-13.28M	$-9.07M
Profit margin	-250,140.00%	-3,687,419.82%	-1,160.23%	-49,290.48%	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
KZIA	$135.07M	36	8.0	2.5	5.3	5.0	—	Hold
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Kazia Therapeutics Ltd ADR trades at $13.64. Our Smart Value Score of 36/100 indicates the stock is weak. TTM revenue stands at $1.90M.

Frequently asked questions

What is Kazia Therapeutics Ltd ADR's stock price?

Kazia Therapeutics Ltd ADR (KZIA) trades at $13.64.

Is Kazia Therapeutics Ltd ADR overvalued?

Smart Value Score 36/100 (Grade D, Sell).

What is the price target of Kazia Therapeutics Ltd ADR (KZIA)?

The analyst target price is $21.26, representing +55.9% upside from the current price of $13.64.

What is Kazia Therapeutics Ltd ADR's revenue?

TTM revenue is $1.90M.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio71.14x

ROE-106.90%

Beta1.62

50D MA$8.07

200D MA$8.11

Shares out0.01B

Float3.91B

Short ratio—

Avg volume0.2M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

KZIA vs LLY →KZIA vs JNJ →KZIA vs ABBV →Stock screener →